Annual report pursuant to Section 13 and 15(d)

Revenue Disaggregation

v3.24.1.1.u2
Revenue Disaggregation
 12 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

NOTE 16 – Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by source:

           
    Year Ended March 31,  
    2024     2023  
Product:            
  Human Care   $ 10,110,000     $ 9,426,000  
  Animal Care     2,203,000       2,500,000  
Total Product Revenue     12,313,000       11,926,000  
Service/Royalty     422,000       1,346,000  
Total   $ 12,735,000     $ 13,272,000  

 

The following table shows the Company’s revenues by geographic region:

           
    Year Ended March 31,  
    2024     2023  
United States   $ 3,058,000     $ 3,428,000  
Europe     4,781,000       4,051,000  
Asia     2,298,000       2,451,000  
Latin America     1,726,000       2,383,000  
Rest of the World     872,000       959,000  
Total   $ 12,735,000     $ 13,272,000